Biotechnology

#Biotechnology #Coronavirus #Covid-19 #Drug development #Drug discovery #Metabolomics #Metabolon #Narrated podcasts #Pharmaceutical

The potential of metabolomics & COVID-19 Vaccine Development

Today’s episode is titled The potential of metabolomics & COVID-19 Vaccine Development, and covers 2 articles taken from the most recent Fall issue of DDW. These articles are titled: Why metabolomics has the potential to transform diagnosis and treatment. & COVID-19 Vaccine Development: dethroning evil King Coronavirus These articles were firstly… Read More

#Podcasts

#Biotechnology #Drug development #Drug discovery

Quotient Sciences CEO talks acquisitions, efficiency and finding cures fast

Mark Egerton, Chief Executive Officer, Quotient Sciences, spoke to Lu Rahman about the company’s acquisition of Arcinova and what it means for the drug discovery sector. Quotient Sciences, the drug development and manufacturing accelerator, recently acquired Arcinova, the UK-based multiservice contract development and manufacturing organisation (CDMO). Boasting over 40 years of… Read More

#Editor's Choice #News #Trending News

#Biotechnology #CRISPR #Genomics

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

ERS Genomics and G+FLAS Life Sciences, a biotechnology company developing research tools and reagents associated with CRISPR technology, have announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio. G+FLAS supports research organisations by providing CRISPR-related biological research services, tools, and reagents. The Ccampany produces all… Read More

#News

#Biotechnology #Clinical trials #Drug development #Pharmaceutical

New psychedelic medicine COO looks to boost pharma and biotech collaborations

Beckley Psytech, a company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed Andy Page as its Chief Operating Officer. Page brings over 25 years’ experience working within global pharmaceutical and medtech organisations in strategic and operation roles. He started his career at SmithKline Beecham before joining… Read More

#Editor's Choice #News

#Biotechnology #Drug targets

Salipro Biotech patent for direct extraction of membrane proteins and library generation

Swedish biotech company Salipro Biotech has announced that the European Patent Office has issued the European Patent No. 3463303, titled “Saposin lipoprotein particles and libraries from crude membranes”. The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMXTM) from cells or crude membranes to enable drug… Read More

#Editor's Choice #News

#Automation / robotics #Biotechnology #Life sciences

SPT Labtech acquires BioMicroLab

SPT Labtech, a global player in the design and development of automated instrumentation and consumables for life science applications, has acquired BioMicroLab, a robotics automation provider for life science laboratories. Headquartered in Northern California, BioMicroLab designs and manufactures laboratory automation equipment for biotechnology and scientific research. BioMicroLab’s extensive range of… Read More

#Editor's Choice #News

#Biotechnology #CRISPR #Genomics #Pharmaceutical #Zebrafish

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio. ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier. ZeClinics is a contract research organisation using zebrafish to carry out services… Read More

#News

#Biotechnology

Innovation and opportunity: Biotech at its best

Lu Rahman looks at the role of the biotech sector in the development of new therapeutics and why this industry is a vital element in drug discovery For reasons we would clearly have preferred not to happen, the global spotlight has  - understandably - been on the biotech sector since… Read More

#Market Reports #News

#AI / data analytics / healthtech / informatics #Biotechnology

Intelligent thinking: the biotech business harnessing the power of AI

Sam Cooper founded Phenomic AI in 2017 alongside Oren Kraus, as an early stage biotech company seeking to commercialise AI approaches for pharmaceutical R&D. He discusses the role of AI in drug discovery with Lu Rahman. LR: Where are we with deep learning and drug discovery and how effective is… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Biotechnology #Pharmaceuticals

Reach Separations pushes expansion plans and alliance with NovAliX 

Purification specialists Reach Separations and French drug discovery CRO, NovAliX, have entered into an alliance to develop supercritical fluid chromatography (SFC) capabilities at the NovAliX facility near Strasbourg. Formed in support of Reach Separations’ strategy to grow its European presence, and in response to a sustained rise in demand for… Read More

#News

#Biologics #Biotechnology #Vaccines

German biotech Leukocare opens in the US

Leukocare, a German biotechnology company specialising in formulation development for biologics, viral vectors and vaccines, has opened development labs in Milford, USA. Its headquarters will remain in Martinsried/Munich, Germany. Being present in the US market offers the opportunity to collaborate closely with customers and partners on tailor-made solutions in the… Read More

#News

#Biotechnology #Drug development #Drug discovery #Health #Life sciences #Narrated podcasts #Pharmaceutical

2030 Life Sciences and Health in the Digital Age (Part 1)

This article is the first in a two-part series based on The Pistoia Alliance report. Written in retrospect from the world as it is in 2030, it looks at how healthcare has changed in the intervening decade, covering the socio-economic and political evolutions that have happened, the subsequent effects on… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Antibodies #Biotechnology #Cancer research #Drug development #Oncology

AI-driven precision medicine for development of HMBD-001 in HER3-driven cancers

Hummingbird Bioscience, a clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, is collaborating with Tempus, an expert in artificial intelligence and precision medicine. This will drive the development of Hummingbird’s lead clinical program, HMBD-001, as it advances into clinical trials in HER3-driven cancers, including those that harbour… Read More

#Cancer Research #News

#Biopharmaceuticals #Biotechnology #Mammalian transient protein #Pharmaceutical

Mammalian transient protein expression market players eye opportunities in biopharma

Global mammalian transient protein market revenues are projected to surpass US$ 540 million in 2020, according to a new study by Future Market Insights. The report also states that, innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and complexity to maintain media purity remain challenges. Read More

#Market Reports #News

#Biotechnology #Cell therapy #Covid-19 #Gene therapy #Immunology / Virology & Vaccines #Pharmaceutical

Investment banking head offers market outlook for 2021

The Jefferies Healthcare Temperature Check report is now in its third edition and published to coincide with the 11th annual Global Healthcare Conference which was held virtually. Over 500 responses from senior leaders in the sector responded for this year’s report, giving views on both the current state of the… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Market Reports #News #Opinion #Trends & Analysis